Richard F Pops insider trades

Open-market stock purchases and sales by Richard F Pops, Director at Neurocrine Biosciences Inc, from SEC Form 4 filings since May 17, 2010.

Recent trades

DateStockTradeValue
May 27, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
May 21, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
May 15, 2026NBIX Neurocrine Biosciences IncSold$2.4M
May 15, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Mar 2, 2026ALKS Alkermes plc.Bought (not open market)—
Feb 5, 2026ALKS Alkermes plc.Bought (not open market)—
Feb 5, 2026ALKS Alkermes plc.Sold (not open market)$2.1M

Companies traded

  • NBIX Neurocrine Biosciences Inc: 12 sales, last May 27, 2026
  • ALKS Alkermes plc.: 103 sales, last Mar 2, 2026
  • EPZM Epizyme, Inc: other filings, last May 29, 2020
  • XLRN Acceleron Pharma Inc: 2 sales, last Jan 25, 2019

Get free alerts when Richard F Pops files a new trade →